These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20846121)

  • 41. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
    Ellis V
    J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasminogen activation by tissue plasminogen activator in the presence of platelets.
    Deguchi K; Shirakawa S
    Thromb Res Suppl; 1988; 8():65-72. PubMed ID: 2974648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha 3 subunit of laminin-5.
    Goldfinger LE; Jiang L; Hopkinson SB; Stack MS; Jones JC
    J Biol Chem; 2000 Nov; 275(45):34887-93. PubMed ID: 10956663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
    Le DM; Besson A; Fogg DK; Choi KS; Waisman DM; Goodyer CG; Rewcastle B; Yong VW
    J Neurosci; 2003 May; 23(10):4034-43. PubMed ID: 12764090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
    Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.
    Sim PS; Fayle DR; Doe WF; Stephens RW
    Eur J Biochem; 1986 Aug; 158(3):537-42. PubMed ID: 2942403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of the plasminogen activator/plasmin system in rat liver regenerating by recruitment of oval cells.
    Bisgaard HC; Santoni-Rugiu E; Nagy P; Thorgeirsson SS
    Lab Invest; 1998 Mar; 78(3):237-46. PubMed ID: 9520937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
    Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
    J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of plasminogen activators and urokinase receptor in platelet kinetics.
    Piguet PF; Vesin C; Da Laperousaz C; Rochat A
    Hematol J; 2000; 1(3):199-205. PubMed ID: 11920190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Tsuboi R; Rifkin DB
    Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
    Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
    Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
    López-Alemany R; Suelves M; Muñoz-Cánoves P
    Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen activator/plasmin system suppresses cell-cell adhesion of oral squamous cell carcinoma cells via proteolysis of E-cadherin.
    Hayashido Y; Hamana T; Yoshioka Y; Kitano H; Koizumi K; Okamoto T
    Int J Oncol; 2005 Sep; 27(3):693-8. PubMed ID: 16077918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelets and plasminogen activation.
    Loscalzo J; Pasche B; Ouimet H; Freedman JE
    Thromb Haemost; 1995 Jul; 74(1):291-3. PubMed ID: 8578474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue plasminogen activator as a modulator of neuronal survival and function.
    Tsirka SE
    Biochem Soc Trans; 2002 Apr; 30(2):222-5. PubMed ID: 12023855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pericellular plasmin induces smooth muscle cell anoikis.
    Meilhac O; Ho-Tin-Noé B; Houard X; Philippe M; Michel JB; Anglés-Cano E
    FASEB J; 2003 Jul; 17(10):1301-3. PubMed ID: 12738809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of urokinase on the proliferation of primary cultures of human prostatic cells.
    Kirchheimer JC; Wojta J; Hienert G; Christ G; Heger ME; Pflüger H; Binder BR
    Thromb Res; 1987 Nov; 48(3):291-8. PubMed ID: 2448891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.